Derivation and validation of the BIMAST score for predicting the presence of fibrosis due to Metabolic dysfunction-associated steatotic liver disease among diabetic patients in the community
The BIMAST predicts the presence of significant fibrosis in the community, reduces false negatives and is cost-effective. The BIMAST score should be included in the holistic assessment of diabetic patients.
Authors
- Tijana Stanic (ORCID: https://orcid.org/0000-0001-6876-8735)
- Emmanuel Tsochatzis (ORCID: https://orcid.org/0000-0001-5069-2461)
- Elias A. Mossialos (ORCID: https://orcid.org/0000-0001-8664-9297)
- Mark R. Thursz (ORCID: https://orcid.org/0000-0002-8218-192X)
- Benjamin H. Mullish (ORCID: https://orcid.org/0000-0001-6300-3100)
- Sahan Jayawardana (ORCID: https://orcid.org/0000-0001-7081-3910)
- Robert Goldin (ORCID: https://orcid.org/0000-0001-5184-4519)
- Salvatore Petta (ORCID: https://orcid.org/0000-0002-0822-9673)
- Roberta Forlano (ORCID: https://orcid.org/0000-0003-4746-7065)
- Pinelopi Manousou (ORCID: https://orcid.org/0000-0002-5363-1565)
- Michael Yee
Institutions
- St Mary's Hospital (GB)
- Global Policy Institute (US)
- University College London (GB)
- Imperial College London (GB)
- University of Palermo (IT)
- London School of Economics and Political Science (GB)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1371/journal.pone.0307500
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Institute for Health and Care Research
- European Association for the Study of the Liver
- Medical Research Council
- NIHR Imperial Biomedical Research Centre